Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-12
2008-12-30
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S009100, C514S018700, C514S019300, C530S331000, C540S455000
Reexamination Certificate
active
07470664
ABSTRACT:
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
REFERENCES:
patent: 2004/0229776 (2004-11-01), Chen et al.
patent: 2004/0229818 (2004-11-01), Llinas-Brunet et al.
patent: 2005/0020503 (2005-01-01), Llinas-Brunet et al.
B. W. Dymock, “Novel Approaches to the Treatment of Hepatitis C Virus Infection”, 2000, pp. 79-86, vol. 11, Antiviral Chemistry & Chemotherapy.
H. R. Rosen et al., “Hepatitis C Virus: Current Understanding and Prospects for Future Therapies”, 1999, pp. 393-399, vol. 5, Molecular Medicine Today.
D. Moradpour et al., “Current and Evolving Therapies for Hepatitis C”, 1999, European J. Gastroenterol. Hepatol.
R. Bartenschlager, “Candidate Targets for Hepatitis C Virus-Specific Antiviral therapy”, 1997, pp. 378-393, vol. 40, N. Engl. Intervirology.
G. M. Lauer et al., “Hepatitis C Virus Infection”, 2001, pp. 41-52, vol. 345, J. Med.
B. W. Dymock, “Emerging Therapies for Hepatitis C Virus Infection”, 2001, pp. 13-42, vol. 6, Emerging Drugs.
C. Crabb, “Hard-Won Advances Spark Excitement about Hepatitis C”, 2001, pp. 506-507, Science.
Holloway M. Katharine
Liverton Nigel J.
Ludmerer Steven W.
McCauley John A.
McIntyre Charles J.
Heber Sheldon O.
Lake Julie M.
Merck & Co. , Inc.
Russel Jeffrey E
LandOfFree
HCV NS3 protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HCV NS3 protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HCV NS3 protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4038249